Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price was up 40.5% during trading on Monday . The company traded as high as $3.68 and last traded at $3.68. Approximately 16,870 shares changed hands during mid-day trading, an increase of 274% from the average daily volume of 4,514 shares. The stock had previously closed at $2.62.
Mayne Pharma Group Stock Up 40.5 %
The company has a fifty day moving average of $2.86 and a two-hundred day moving average of $2.85.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Featured Stories
- Five stocks we like better than Mayne Pharma Group
- What is the S&P/TSX Index?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Bank Stocks – Best Bank Stocks to Invest In
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Profit From Value Investing
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
